Imc Chicago, LLC Tg Therapeutics, Inc. Transaction History

Imc Chicago, LLC

$3.02 Billion
Q3 2024

A detailed history of Imc Chicago, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Imc Chicago, LLC holds 15,698 shares of TGTX stock, worth $504,847. This represents 0.01% of its overall portfolio holdings.

Number of Shares

15,698

Holding current value

$504,847

% of portfolio

0.01%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Oct 25, 2024	BUY	$17.21 - $25.28 $270,162 - $396,845	15,698 New	15,698 $367,000
Q4 2023 Feb 09, 2024	BUY	$6.68 - $18.81 $126,719 - $356,825	18,970 New	18,970 $324,000

Others Institutions Holding TGTX

# of Institutions

338

Shares Held

87.7M

Call Options Held

2.35M

Put Options Held

1.7M

Vanguard Group Inc Valley Forge, PA

15.4M
Shares

$495 Million
0.01% of portfolio
Black Rock Inc. New York, NY

11.4M
Shares

$366 Million
0.0% of portfolio
State Street Corp Boston, MA

9.09M
Shares

$292 Million
0.01% of portfolio
Pictet Asset Management Holding Sa Carouge, V8

3.58M
Shares

$115 Million
0.1% of portfolio
Geode Capital Management, LLC Boston, MA

3.21M
Shares

$103 Million
0.01% of portfolio

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.67B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Imc Chicago, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Imc Chicago, LLC with notifications on news.

Account